×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北京... [7]
四川大学 [3]
西安交通大学 [2]
中南大学 [2]
山东大学 [1]
武汉大学 [1]
更多...
内容类型
期刊论文 [19]
发表日期
2018 [6]
2017 [3]
2016 [3]
2015 [1]
2014 [1]
2013 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共19条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 卷号: 11
作者:
Zhao, Wan-Hong
;
Liu, Jie
;
Wang, Bai-Yan
;
Chen, Yin-Xia
;
Cao, Xing-Mei
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/11/26
BCMA
Refractory
Relapsed
CAR T
Multiple myeloma
Chimeric antigen receptor
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: a meta-analysis
期刊论文
BMC CANCER, 2018, 卷号: Vol.18
作者:
Zhou, Hui
;
Luo, Yuling
;
Zhu, Sha
;
Wang, Xi
;
Zhao, Yunuo
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/02/28
Chimeric
antigen
receptor
T
(CAR
T)
therapy
Safety
Efficacy
Relapsed
or
refractory
B-cell
malignancies
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia.
期刊论文
International journal of hematologic oncology, 2018, 卷号: No.2, 页码: IJH06
作者:
Ma Jun
;
Liu Ting
;
Jin Jie
;
Hu Jianda
;
Liu Qifa
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/02/28
ALL
China
Philadelphia
chromosome-negative
B-cell
precursor
acute
lymphoblastic
leukemia
acute
lymphoblastic
leukemia
chemotherapy
relapsed/refractory
retrospective
observational
study
Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10
作者:
Luo, Xian-Wu
;
Du, Xue-Qing
;
Li, Jie-Li
;
Liu, Xiao-Ping
;
Meng, Xiang-Yu
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
multiple myeloma
refractory/relapsed
treatment regimens
efficacy
network meta-analysis
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia
期刊论文
2018, 卷号: 7, 期号: 2, 页码: IJH06
作者:
Ma Jun
;
Liu Ting
;
Jin Jie
;
Hu Jianda
;
Liu Qifa
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
ALL
China
Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia
acute lymphoblastic leukemia
chemotherapy
relapsed/refractory
retrospective observational study
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus
期刊论文
2018, 卷号: 97, 期号: 11, 页码: 2047-2054
作者:
Long, Zhangbiao
;
Yu, Fan
;
Du, Yali
;
Li, Hongmin
;
Chen, Miao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Acquired pure red cell aplasia
Refractory
relapsed
Cyclosporine A
Sirolimus
Regulatory T cells
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
期刊论文
Journal of Hematology & Oncology, 2017, 卷号: 10, 期号: 1, 页码: 137
作者:
Hou, Jian*
;
Jin, Jie
;
Xu, Yan
;
Wu, Depei
;
Ke, Xiaoyan
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/03
China
Ixazomib
Multiple myeloma
Oral
Overall survival
Progression-free survival
Proteasome inhibitor
Relapsed/refractory
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
期刊论文
2017, 卷号: 10, 期号: 1, 页码: 137
作者:
Hou, Jian
;
Jin, Jie
;
Xu, Yan
;
Wu, Depei
;
Ke, Xiaoyan
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/04
China
Ixazomib
Multiple myeloma
Oral
Overall survival
Progression-free survival
Proteasome inhibitor
Relapsed/refractory
Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review
期刊论文
2017, 卷号: 17, 页码: 87-91
作者:
Xue Jingwen
;
Liu Cynthia
;
Liu Yuehua
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Photodynamic therapy
Relapsed or refractory mycosis fungoides
Aminolevulinic acid
Methyl aminolevulinic acid
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma
期刊论文
Chinese Journal of Cancer, 2016, 卷号: 第35卷, 页码: P699-705
作者:
Leng Yun
;
Qiu Lugui
;
Hou Jian
;
Zhao Yaozhong
;
Zhang Xuejun
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/02/28
Recombinant human circularly permuted TRAIL Phase II trial Relapsed or refractory multiple myeloma Efficacy Safety
©版权所有 ©2017 CSpace - Powered by
CSpace